The North America Crohn’s disease therapeutics market is witnessing steady expansion driven by rising disease prevalence, advancements in biologics, and strong healthcare infrastructure. Crohn’s disease, a chronic inflammatory bowel disorder, requires long-term treatment approaches, which has significantly boosted demand for innovative therapeutics across the region....